Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.

Dastsooz H, Nemati H, Fard MAF, Fardaei M, Faghihi MA.

BMC Med Genet. 2017 Aug 18;18(1):87. doi: 10.1186/s12881-017-0439-y.

2.

A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir - India.

Angural A, Singh I, Mahajan A, Pandoh P, Dhar MK, Kaul S, Verma V, Rai E, Razdan S, Kishore Pandita K, Sharma S.

Sci Rep. 2017 Jul 5;7(1):4834. doi: 10.1038/s41598-017-05388-9.

3.
4.

Contributions to magnetic susceptibility of brain tissue.

Duyn JH, Schenck J.

NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3546. Epub 2016 May 30. Review.

5.

Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management.

Kumar N, Rizek P, Jog M.

Tremor Other Hyperkinet Mov (N Y). 2016 Mar 17;6:355. doi: 10.7916/D8KK9BHF. eCollection 2016. Review.

6.

Brain iron deposits and lifespan cognitive ability.

Del C Valdés Hernández M, Ritchie S, Glatz A, Allerhand M, Muñoz Maniega S, Gow AJ, Royle NA, Bastin ME, Starr JM, Deary IJ, Wardlaw JM.

Age (Dordr). 2015 Oct;37(5):100. doi: 10.1007/s11357-015-9837-2. Epub 2015 Sep 17.

7.

Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Walker RH.

J Mov Disord. 2015 May;8(2):41-54. doi: 10.14802/jmd.15009. Epub 2015 May 31. Review.

8.

Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.

Arber CE, Li A, Houlden H, Wray S.

Neuropathol Appl Neurobiol. 2016 Apr;42(3):220-41. doi: 10.1111/nan.12242. Epub 2015 Jun 2. Review.

9.

Cortical pencil lining in neuroferritinopathy: a diagnostic clue.

Batla A, Adams ME, Erro R, Ganos C, Balint B, Mencacci NE, Bhatia KP.

Neurology. 2015 Apr 28;84(17):1816-8. doi: 10.1212/WNL.0000000000001511. Epub 2015 Apr 1. No abstract available.

10.

Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism.

Levi S, Rovida E.

Neurobiol Dis. 2015 Sep;81:134-43. doi: 10.1016/j.nbd.2015.02.007. Epub 2015 Mar 12. Review.

11.

Magnetic resonance imaging markers for early diagnosis of Parkinson's disease.

Marino S, Ciurleo R, Di Lorenzo G, Barresi M, De Salvo S, Giacoppo S, Bramanti A, Lanzafame P, Bramanti P.

Neural Regen Res. 2012 Mar 15;7(8):611-9. doi: 10.3969/j.issn.1673-5374.2012.08.009. Review.

12.

Neurodegeneration with brain iron accumulation: an overview.

Tonekaboni SH, Mollamohammadi M.

Iran J Child Neurol. 2014 Fall;8(4):1-8. Review.

13.

A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.

Maccarinelli F, Pagani A, Cozzi A, Codazzi F, Di Giacomo G, Capoccia S, Rapino S, Finazzi D, Politi LS, Cirulli F, Giorgio M, Cremona O, Grohovaz F, Levi S.

Neurobiol Dis. 2015 Sep;81:119-33. doi: 10.1016/j.nbd.2014.10.023. Epub 2014 Nov 4.

14.

Hallervorden-Spatz disease.

Dashti M, Chitsaz A.

Adv Biomed Res. 2014 Sep 12;3:191. doi: 10.4103/2277-9175.140623. eCollection 2014.

15.

Clinical and molecular research of neuroacanthocytosis.

Zhang L, Wang S, Lin J.

Neural Regen Res. 2013 Mar 25;8(9):833-42. doi: 10.3969/j.issn.1673-5374.2013.09.008.

16.

GRE T2∗-weighted MRI: principles and clinical applications.

Tang MY, Chen TW, Zhang XM, Huang XH.

Biomed Res Int. 2014;2014:312142. doi: 10.1155/2014/312142. Epub 2014 Apr 16. Review.

17.

Novel compound heterozygous mutations in the pantothenate kinase 2 gene in a korean patient with atypical pantothenate kinase associated neurodegeneration.

Kim SH, Sung YH, Park KH, Lee YB, Park HM, Shin DJ, Kim GH.

J Mov Disord. 2009 May;2(1):45-7. doi: 10.14802/jmd.09012. Epub 2009 Apr 30.

18.

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Levi S, Finazzi D.

Front Pharmacol. 2014 May 7;5:99. doi: 10.3389/fphar.2014.00099. eCollection 2014. Review.

19.

A novel ferritin light chain mutation in neuroferritinopathy with an atypical presentation.

Nishida K, Garringer HJ, Futamura N, Funakawa I, Jinnai K, Vidal R, Takao M.

J Neurol Sci. 2014 Jul 15;342(1-2):173-7. doi: 10.1016/j.jns.2014.03.060. Epub 2014 Apr 12.

20.

Enhanced susceptibility-weighted angiography (ESWAN) of cerebral arteries and veins at 1.5 Tesla.

Chen L, Zhang J, Wang QX, Peng L, Luo X, Zhu WZ, Roshan AK, Qi JP, Wang H.

Br J Radiol. 2014 Jul;87(1039):20130486. doi: 10.1259/bjr.20130486. Epub 2014 May 2.

Supplemental Content

Support Center